SS Innovations International, Inc. (NASDAQ: SSII) is a Healthcare company (Medical - Devices) with a market capitalization of $267M. The Maz Rating grades it against the other companies in its sector.
SS Innovations International, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.33, SS Innovations International, Inc. trades at 5.9x sales and 5.4x book value. Over the last twelve months it generated about $46M of revenue and a net loss of $15M. It runs a gross margin of 47.0%, an operating margin of -27.7% and a net margin of -31.5%. It shows return on equity of -29.5%, return on invested capital of -15.8% and a free cash flow yield of -6.7%. On the balance sheet: a debt-to-equity ratio of 0.40 and a current ratio of 2.10. Over the past 52 weeks the share price ranged from $1.12 to $6.79, with a beta of 0.73.
SS Innovations International, Inc. does not currently pay a dividend.
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, SS Innovations International, Inc. (SSII) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 3.57% / 30% · (Cash+Inv) / Mkt Cap (36m) 1.45% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 3.57% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 1.45% / 33% · Receivables / Mkt Cap (36m) 3.00% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 3.57% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 1.45% / 33.33% · Receivables / Mkt Cap (24m) 3.00% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 12.0% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 11.4% / 33.33% · Receivables / Avg Assets (4Q) 20.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 20.6% / 33.33% · (Cash+ST Inv) / Total Assets 8.41% / 33.33% · (Cash+Recv) / Total Assets 25.8% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of September 2026, SS Innovations International, Inc. (SSII) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. SS Innovations International, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
SS Innovations International, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.